肝移植后的脆弱变化. 来自西班牙多中心前性队列研究的结果
Lorena Puchades1,2, Julia Herreras1, Maria Àngels Cebrià I Iranzo3,4,5
1Hepatology and Liver Transplantation Group, Medical Research Institute Hospital La Fe, Valencia, Spain.
Transplantation direct
|March 26, 2024
概括
肝移植 (LT) 接受者表现不完整的身体虚弱恢复. 通过肝脏脆弱指数 (LFI) 测量的移植前脆弱性预测了移植后的结果. 建议对LT候选人进行客观和主观的评估.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植医学 移植医学
- 老年病的医生 老年病的医生
背景情况:
- 有限的证据表明,肝移植 (LT) 后的结局是脆弱,主要来自美国队列.
- 脆弱性评估对于优化LT候选人和接受者的患者结果至关重要.
研究的目的:
- 调查欧洲队列中肝移植前和肝移植后 (LT) 脆弱性之间的关系.
- 评估LT后3个月和6个月的脆弱状态的变化.
主要方法:
- 在西班牙5个中心 (2018-2020年) 对180名LT接收者的前性分析.
- 使用肝脏脆弱指数 (LFI) 进行客观的脆弱性评估.
- 在LT前后使用主观临床评估 (SCA) 进行主观脆弱性评估.
主要成果:
- 肝脏脆弱指数 (LFI) 在3个月后变化很小,但在LT后6个月显著改善 (P=0.001).
- 主观临床评估 (SCA) 显示LT后的早期和持续改善 (P<0.001),但与LFI的一致性不佳.
- 更高的移植前LFI得分与LT后强壮的可能性降低有显著的相关性 (OR=0.75在3分钟,OR=0.74在6分钟).
结论:
- 在这个欧洲队列中,在LT后的6个月内,身体虚弱的改善是不完整的,只有不到20%的人达到强壮的状态.
- 移植前的LFI是移植后脆弱性的强有力的预测因素.
- 建议将主观 (SCA) 和客观 (LFI) 脆弱性评估结合起来,以对LT候选人和接受者进行全面评估.
相关概念视频
01:30Liver Physiology
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...